Latest News

Newer antiretroviral drugs and the introduction of long-acting regimens have prompted more frequent therapy switches in individuals on suppressive antiretroviral therapy. For these individuals, the use of DNA from peripheral blood lymphocytes for the assessment of HIV drug resistance has become increasingly popular. HIV DNA resistance testing as an alternative to HIV RNA-based analyses in [...]

This episode of Going anti-Viral, features Rebecca Denison, who gave the Martin Delaney Presentation, entitled 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must, at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI). Ms Denison is the founder of Woman Organized to Respond to Life-threatening Diseases or (WORLD). Resources: CROI 2025: [...]

Listen to special podcasts and watch presentations and videos featuring voices in HIV research and global health from the scientists, the labs, and the community. Listen or Watch Here

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Tonia Poteat, a professor in the Duke University School of Nursing and co-director of the Duke SGM Wellness Program. Dr Poteat joins Dr Saag to provide an overview of a Themed Discussion session that she is leading at CROI 2025 entitled Meeting the [...]

Certain mutations in HIV-1 that emerge during exposure to antiretroviral drugs may have varied impact on the effectiveness of current and subsequent treatments for HIV. This 2025 edition of the IAS–USA drug resistance mutations list updates the Figure last published in November 2022 based on new data that have become available. The Figure is designed […]

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Diane Havlir, Professor of Medicine at the University of California San Francisco. Dr Havlir currently serves as Chair of the Scientific Program Committee for the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) and joins Dr Saag to provide a preview of CROI [...]

The Last Gift Program: Lessons Learned From Altruistic Participants Enrolled in HIV Cure Research at the End of Life Presenter: Sara Gianella Weibel, MD Moderator: Davey M. Smith, MD March 21, 2025 10:00 AM – 11:15 AM PT This webinar explores the invaluable contributions of altruistic individuals who enrolled in HIV cure research programs at […]

Basic Principles and Clinical Relevance of the 2025 Update of the Drug Resistance Mutations in HIV-1 Presenter: Annemarie M. Wensing, MD, PhD Moderator: Douglas D. Richman, MD Panelists: Roger Paredes, MD, PhD, Robert W. Shafer, MD, Francesca Ceccherini Silberstein, PhD March 26, 2025 10:00 AM – 11:30 AM PT   This webinar will review the […]

In this insightful IAS-USA Dialogue, our distinguished panel of infectious diseases experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, this Dialogue brings together world-class experts […]